1. US Centers for Disease Control and Prevention (CDC). Antibiotic resistance threats in the United States, 2013. Atlanta, GA: US Department of Health and Human Services, CDC; 2013. http://www.cdc.gov/drugresistance/pdf/ar-threats-2013-508.pdf[accessed 5/12/2015].
2. US Centers for Disease Control and Prevention (CDC). Antibiotic resistance threats in the United States, 2019. Atlanta, GA: US Department of Health and Human Services, CDC; 2019. https://www.cdc.gov/drugresistance/pdf/threats-report/2019-ar-threats-report-508.pdf [accessed 01/05/2020].
3. Emergence of ceftazidime–avibactam resistance and restoration of carbapenem susceptibility in Klebsiella pneumoniae carbapenemase-producing K pneumoniae: a case report and review of literature;Shields;Open Forum Infect Dis,2017
4. In vitro selection of aztreonam/avibactam resistance in dual-carbapenemase-producing Klebsiella pneumoniae;Niu;J Antimicrob Chemother,2020
5. Excess deaths associated with tigecycline after approval based on noninferiority trials;Prasad;Clin Infect Dis,2012